Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glioma stem cells and their roles within the hypoxic tumor microenvironment
Nathaniel Boyd, Anh Tran, Joshua D. Bernstock, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 665-683
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Shaping the brain vasculature in development and disease in the single-cell era
Thomas Wälchli, Jeroen Bisschop, Peter Carmeliet, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 5, pp. 271-298
Open Access | Times Cited: 77
Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
Jang Hyun Park, Heung Kyu Lee
Cancers (2022) Vol. 14, Iss. 5, pp. 1176-1176
Open Access | Times Cited: 70
An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma
Silvia Mara Baez Rodriguez, A. El Kamel, Gheorghe Vasile Ciubotaru, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11110-11110
Open Access | Times Cited: 47
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 31
Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy
Wei Xu, Guoqiang Guan, Renye Yue, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 5
Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment
Liyin Wang, Min Gu, Xiaoli Zhang, et al.
Advanced Science (2025)
Open Access | Times Cited: 4
Distinct myeloid-derived suppressor cell populations in human glioblastoma
Christina Jackson, Christopher Cherry, Sadhana Bom, et al.
Science (2025) Vol. 387, Iss. 6731
Closed Access | Times Cited: 3
Hypoxia: molecular pathophysiological mechanisms in human diseases
Ylenia Della Rocca, Luigia Fonticoli, Thangavelu Soundara Rajan, et al.
Journal of Physiology and Biochemistry (2022) Vol. 78, Iss. 4, pp. 739-752
Open Access | Times Cited: 56
Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma
Ge Zhang, Xiang Tao, Baowei Ji, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 41
HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis
Xiaodong Su, Yuan Xie, Junwen Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 39
Alleviating hypoxia to improve cancer immunotherapy
Peng Fan, Naidong Zhang, Eleonora Candi, et al.
Oncogene (2023) Vol. 42, Iss. 49, pp. 3591-3604
Closed Access | Times Cited: 37
Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review
Gayathree Thenuwara, James F. Curtin, Furong Tian
Sensors (2023) Vol. 23, Iss. 24, pp. 9842-9842
Open Access | Times Cited: 37
Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a/β-Catenin and Akt/NF-κB signaling pathways
Wanyu Wang, Xiaopeng Yuan, Jiasheng Mu, et al.
Phytomedicine (2023) Vol. 118, pp. 154933-154933
Closed Access | Times Cited: 27
Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner
Min Li, Pingfeng Sun, Binfeng Tu, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 2, pp. C487-C504
Closed Access | Times Cited: 15
Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity
Haidong Huang, Hariti Shah, Hao Jing, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 8, pp. 1388-1401
Closed Access | Times Cited: 11
Artificial intelligence-based MRI radiomics and radiogenomics in glioma
Haiqing Fan, Yilin Luo, Fang Gu, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Glioma stem cell membrane-camouflaged photothermal nanozyme for synergistic antitumor via dual-targeted drug delivery across blood-brain barrier
Jialiang Lin, Zuoming Sun, Yue Huang, et al.
Chemical Engineering Journal (2025), pp. 160181-160181
Open Access | Times Cited: 1
Challenges and Material Innovations in Drug Delivery to Central Nervous System Tumors
Zhenyu Gong, Dairan Zhou, Dejun Wu, et al.
Biomaterials (2025) Vol. 319, pp. 123180-123180
Closed Access | Times Cited: 1
Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis
Jiao Deng, Yangkun Li, Lanlan Yin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme
Sai Qiao, Ying Cheng, Miao Liu, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 54-70
Open Access | Times Cited: 46
Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy S Precilla, Indrani Biswas, Shreyas S. Kuduvalli, et al.
Cellular Signalling (2022) Vol. 95, pp. 110350-110350
Closed Access | Times Cited: 36
Investigational PET tracers in neuro-oncology—What’s on the horizon? A report of the PET/RANO group
Norbert Galldiks, Karl‐Josef Langen, Nathalie L. Albert, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 11, pp. 1815-1826
Open Access | Times Cited: 30
Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
Andrew M. Hersh, Hallie Gaitsch, Safwan Alomari, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3743-3743
Open Access | Times Cited: 30
The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma
Tingyu Shi, Jun Zhu, Xiang Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2613-2613
Open Access | Times Cited: 21
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top